APA

Daoud M. A., Aboelnaga E. M., Alashry M. S., Fathy S. & Aletreby M. A. (2017). Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients. : OncoTargets and therapy.

Chicago

Daoud Mohamed A, Aboelnaga Engy M, Alashry Mohamed S, Fathy Salwa and Aletreby Mostafa A. 2017. Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients. : OncoTargets and therapy.

Harvard

Daoud M. A., Aboelnaga E. M., Alashry M. S., Fathy S. and Aletreby M. A. (2017). Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients. : OncoTargets and therapy.

MLA

Daoud Mohamed A, Aboelnaga Engy M, Alashry Mohamed S, Fathy Salwa and Aletreby Mostafa A. Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients. : OncoTargets and therapy. 2017.